Skip to main content
OpenTrials
Completed

NCT Number: NCT07441863

Structured Pulmonary Physiotherapy After Lung Cancer Surgery by Age Group

This prospective, single-arm interventional study aims to evaluate the effectiveness of a structured postoperative pulmonary physiotherapy program delivered by the research team in patients undergoing lung cancer surgery. The intervention consists of chest physiotherapy, bronchial hygiene techniques, early mobilization, and postural exercises applied under physiotherapist supervision during the postoperative hospital stay.

The primary outcome is length of hospital stay. Secondary outcomes include blood pressure, heart rate, oxygen saturation, fatigue, and dyspnea levels. Clinical outcomes will be analyzed according to age groups (45-59 years and 60-90 years) to determine potential age-related differences in response to the intervention.

Completed

Looking for future studies?

Notify Me

Key information

Age range

45 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Bezmialem Vakif University

Istanbul, Turkey (Türkiye)

About this study

This interventional study aims to evaluate the effectiveness of a structured pulmonary physiotherapy program applied after lung cancer surgery across different age groups. Patients aged 45 years and older undergoing lung resection will be included and categorized into two age groups (45-60 years and ≥60 years) for subgroup analysis.

The structured postoperative pulmonary physiotherapy program is initiated in the early postoperative period and continued until hospital discharge. The program includes chest physiotherapy techniques, early mobilization, postural exercises, and incentive spirometry training. The intervention is delivered once daily under physiotherapist supervision, and participants are instructed to continue prescribed breathing, incentive spirometry, and mobilization exercises independently during the afternoon and evening sessions.

The primary outcome measure is length of hospital stay. Secondary outcomes include postoperative pain assessed by Visual Analog Scale (VAS), dyspnea and fatigue assessed by Borg scale, oxygen saturation, hemodynamic parameters, and inflammatory and biochemical markers including C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), albumin, prealbumin, creatine kinase (CK), and lactate dehydrogenase (LDH).

Clinical, physiological, and biochemical outcomes are assessed from the early postoperative period until hospital discharge. The study further aims to explore potential differences in treatment response between predefined age groups. No randomization or control group is included, as all participants receive the same structured physiotherapy intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 45 to 90 years
  • Undergoing lung cancer surgery (lobectomy, segmentectomy, or pneumonectomy)
  • Medically stable in the early postoperative period
  • Able to participate in a structured pulmonary physiotherapy program
  • Provided written informed consent

Exclusion criteria

  • Hemodynamic instability preventing mobilization
  • Severe cognitive impairment limiting cooperation
  • Neurological or orthopedic conditions restricting mobilization
  • Requirement for prolonged mechanical ventilation
  • Presence of another active malignancy
  • Any medical contraindication to physiotherapy as determined by the attending physician

Treatment and study plan

Structured Postoperative Pulmonary Physiotherapy Program

Behavioral

The structured postoperative pulmonary physiotherapy program is delivered by the research team during the hospital stay following lung cancer surgery. The intervention is applied according to a standardized protocol and includes supervised chest physiotherapy techniques (deep breathing exercises, thoracic expansion exercises, airway clearance techniques, and incentive spirometry), early mobilization (progressive sitting, standing, and ambulation), and postural exercises.

The program is administered once daily under physiotherapist supervision. In addition, participants are instructed to continue the prescribed breathing, incentive spirometry, and mobilization exercises independently during the afternoon and evening sessions. The intervention is initiated in the early postoperative period and continues until hospital discharge.

Primary outcomes

  1. Length of Hospital Stay

    Time frame: Postoperative period, from ward admission after surgery until hospital discharge (maximum 30 postoperative days)

    Length of hospital stay is defined as the number of days from postoperative admission to the ward until hospital discharge following lung cancer surgery.

  2. C-reactive protein (CRP)

    Time frame: Postoperative Day 1 and at hospital discharge (up to 30 days after surgery)

    Serum CRP levels (mg/L) will be measured to evaluate postoperative systemic inflammatory response.

  3. Peripheral Oxygen Saturation (SpO₂)

    Time frame: Postoperative Day 1 and at hospital discharge (up to 30 days after surgery)

    Peripheral oxygen saturation (%) will be measured using pulse oximetry to assess postoperative oxygenation status.

Secondary outcomes

  1. Neutrophil-to-Lymphocyte Ratio (NLR)

    Time frame: Postoperative Day 1 and at hospital discharge (up to 30 days after surgery)

    NLR will be calculated from complete blood count parameters to assess systemic inflammatory status.

  2. Serum Albumin

    Time frame: Postoperative Day 1 and at hospital discharge (up to 30 days after surgery)

    Serum albumin levels (g/dL) will be measured to assess nutritional status.

  3. Systolic Blood Pressure

    Time frame: Postoperative Day 1 and at hospital discharge (up to 30 days after surgery)

    Systolic blood pressure (mmHg) will be recorded to assess postoperative hemodynamic response.

  4. Diastolic Blood Pressure

    Time frame: Postoperative Day 1 and at hospital discharge (up to 30 days after surgery)

    Diastolic blood pressure (mmHg) will be recorded to assess postoperative hemodynamic response.

  5. Heart Rate

    Time frame: Postoperative Day 1 and at hospital discharge (up to 30 days after surgery)

    Heart rate (beats per minute) will be measured to evaluate cardiovascular response during the postoperative period.

  6. Dyspnea Severity

    Time frame: Postoperative Day 1 and at hospital discharge (up to 30 days after surgery)

    Dyspnea severity will be assessed using the Modified Borg Dyspnea Scale (0-10), where 0 indicates "no breathlessness" and 10 indicates "maximal breathlessness."

  7. Fatigue Severity

    Time frame: Postoperative Day 1 and at hospital discharge (up to 30 days after surgery)

    Fatigue will be assessed using the Borg Rating of Perceived Exertion (0-10), where higher scores indicate greater perceived fatigue.

  8. Incisional Pain Intensity

    Time frame: Postoperative Day 1 and at hospital discharge (up to 30 days after surgery)

    Incisional pain will be evaluated using the Numeric Rating Scale (NRS, 0-10), where 0 represents "no pain" and 10 represents "worst imaginable pain."

Sponsors and collaborators

Lead sponsor

Bezmialem Vakif University

Other

Registry information

Official study title

Age-Related Effects of a Structured Postoperative Pulmonary Physiotherapy Program After Lung Cancer Surgery: A Prospective Interventional Study

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Mar 2, 2026
Registry last updated
Mar 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.